Niemi M - Search Results

1

Cyclosporine markedly raises the plasma concentrations of repaglinide.

Kajosaari LI, Niemi M, Neuvonen M, Laitila J, Neuvonen PJ, Backman JT. Kajosaari LI, et al. Among authors: niemi m. Clin Pharmacol Ther. 2005 Oct;78(4):388-99. doi: 10.1016/j.clpt.2005.07.005. Clin Pharmacol Ther. 2005. PMID: 16198658 Clinical Trial.

2

The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.

Ramsey LB, Johnson SG, Caudle KE, Haidar CE, Voora D, Wilke RA, Maxwell WD, McLeod HL, Krauss RM, Roden DM, Feng Q, Cooper-DeHoff RM, Gong L, Klein TE, Wadelius M, Niemi M. Ramsey LB, et al. Among authors: niemi m. Clin Pharmacol Ther. 2014 Oct;96(4):423-8. doi: 10.1038/clpt.2014.125. Epub 2014 Jun 11. Clin Pharmacol Ther. 2014. PMID: 24918167 Free PMC article.

3

International Transporter Consortium commentary on clinically important transporter polymorphisms.

Giacomini KM, Balimane PV, Cho SK, Eadon M, Edeki T, Hillgren KM, Huang SM, Sugiyama Y, Weitz D, Wen Y, Xia CQ, Yee SW, Zimdahl H, Niemi M; International Transporter Consortium. Giacomini KM, et al. Among authors: niemi m. Clin Pharmacol Ther. 2013 Jul;94(1):23-6. doi: 10.1038/clpt.2013.12. Clin Pharmacol Ther. 2013. PMID: 23778707

4

The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.

Wilke RA, Ramsey LB, Johnson SG, Maxwell WD, McLeod HL, Voora D, Krauss RM, Roden DM, Feng Q, Cooper-Dehoff RM, Gong L, Klein TE, Wadelius M, Niemi M; Clinical Pharmacogenomics Implementation Consortium (CPIC). Wilke RA, et al. Among authors: niemi m. Clin Pharmacol Ther. 2012 Jul;92(1):112-7. doi: 10.1038/clpt.2012.57. Epub 2012 May 23. Clin Pharmacol Ther. 2012. PMID: 22617227 Free PMC article.

5

UDP-glucuronosyltransferase (UGT) polymorphisms affect atorvastatin lactonization in vitro and in vivo.

Riedmaier S, Klein K, Hofmann U, Keskitalo JE, Neuvonen PJ, Schwab M, Niemi M, Zanger UM. Riedmaier S, et al. Among authors: niemi m. Clin Pharmacol Ther. 2010 Jan;87(1):65-73. doi: 10.1038/clpt.2009.181. Epub 2009 Sep 30. Clin Pharmacol Ther. 2010. PMID: 19794410

6

Transporter pharmacogenetics and statin toxicity.

Niemi M. Niemi M. Clin Pharmacol Ther. 2010 Jan;87(1):130-3. doi: 10.1038/clpt.2009.197. Epub 2009 Nov 4. Clin Pharmacol Ther. 2010. PMID: 19890253 Review.

7

Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake.

Niemi M, Pasanen MK, Neuvonen PJ. Niemi M, et al. Pharmacol Rev. 2011 Mar;63(1):157-81. doi: 10.1124/pr.110.002857. Epub 2011 Jan 18. Pharmacol Rev. 2011. PMID: 21245207 Review.

8

Warfarin dose requirement in patients having severe thrombosis or thrombophilia.

Helin TA, Joutsi-Korhonen L, Asmundela H, Niemi M, Orpana A, Lassila R. Helin TA, et al. Among authors: niemi m. Br J Clin Pharmacol. 2019 Aug;85(8):1684-1691. doi: 10.1111/bcp.13948. Epub 2019 Jun 17. Br J Clin Pharmacol. 2019. PMID: 30933373 Free PMC article.

9

Clinical Studies on Drug-Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation.

Tornio A, Filppula AM, Niemi M, Backman JT. Tornio A, et al. Among authors: niemi m. Clin Pharmacol Ther. 2019 Jun;105(6):1345-1361. doi: 10.1002/cpt.1435. Epub 2019 Apr 20. Clin Pharmacol Ther. 2019. PMID: 30916389 Free PMC article. Review.

10

Transporter-Mediated Alterations in Patients With NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 Substrate.

Ali I, Slizgi JR, Kaullen JD, Ivanovic M, Niemi M, Stewart PW, Barritt AS 4th, Brouwer KLR. Ali I, et al. Among authors: niemi m. Clin Pharmacol Ther. 2017 Dec 22:10.1002/cpt.997. doi: 10.1002/cpt.997. Online ahead of print. Clin Pharmacol Ther. 2017. PMID: 29271075 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results